Clinical Trials Logo
  1. Home
  2. Bacteremia
  3. NCT02869191
  4. Details
NCT02869191 Clinical Trial

Blood Cultures's Profitability in Intensive Care Unit

Bacteremia Clinical Trial

Official title:
Blood Cultures's Profitability in Intensive Care Unit

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02869191
Other study ID # blood cultures
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2012
Est. completion date July 2018

Study information
Verified date August 2018
Source Hospital Universitario Getafe
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to assess the blood cultures' profitability in intensive care unit and create a validated prediction rule for extractioning in critical patients.

Description:

Implementing a predictive rule blood cultures to determine the probability of positive or negative result, improving the profitability of the diagnostic test.

Recruitment information / eligibility
Status Completed
Enrollment 900
Est. completion date July 2018
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who have been extracted blood culture sample

Exclusion Criteria:

- Under-aged, pregnants, Major burns.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Spain Hopsital Universitario de Getafe Getafe Madrid

Sponsors (1)
Lead Sponsor Collaborator
Hospital Universitario Getafe

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Other Contamination rates of blood cultures 1 year
Primary Percentage of positive, negative and contaminated blood cultures 2 years
Secondary Percentage of positive, negative and contaminated blood cultures after training program the effect of applying a blood culture extraction protocol is measured 9 months
See also
  Status Clinical Trial Phase
Completed NCT03894046 - Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex Phase 3
Active, not recruiting NCT03354338 - Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy Phase 2
Withdrawn NCT02543957 - Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Completed NCT02210169 - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates N/A
Completed NCT01410578 - The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUO N/A
Completed NCT00609375 - Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen Phase 4
Terminated NCT00428051 - Colombia Epidemiologic Surveillance Study N/A
Terminated NCT00108433 - Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections Phase 3
Completed NCT00177736 - Pharmacodynamic Parameters of Two Different Doses of Cefepime Phase 4
Completed NCT00571259 - Prophylactic Antimicrobial Catheter Lock Phase 4
Completed NCT00027248 - Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections Phase 3
Completed NCT05585463 - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Recruiting NCT05950984 - Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
Completed NCT03148769 - Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors
Completed NCT02536352 - Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being Early Phase 1
Terminated NCT01734694 - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients Phase 4
Completed NCT01179022 - Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions N/A
Recruiting NCT00404625 - Infections Caused by ESbL-Producing Enterobacteriaceae in Italy N/A
Completed NCT00398411 - Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells Phase 3
Recruiting NCT00901602 - Lebanese Interhospital Pneumococcal Surveillance Program